Amarantus Bioscience Holdings Inc (AMBS)

[dsw]

However, if we do not believe we have achieved sufficient shareholder value creation, we will consider delaying the up list until such time as the market recognizes our true value. - See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/fundamental-milestones-ahead-listing-strength/#sthash.BkaTrbiI.dpuf

This basically means, that there will be no uplist in 2014 as there was no uplist in 2013 (when he promised it as well).

This is a good way to postpone uplisting until they are ready to sell the MANF IP to somebody else.